ArticleDrug delivery and translational research2011

Argonaute2 is a potential target for siRNA-based cancer therapy for HT1080 human fibrosarcoma.

Tatsuaki Tagami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.